Walter Ogier

Walter Ogier is a business advisor at Kodikaz Therapeutic Solutions. Walter has also served on the board of directors for Nemucore Medical Innovations, Inc., Regenacy Pharmaceuticals LLC, and Biothera Pharmaceuticals, Inc.

Ogier has over 25 years of experience in the pharmaceutical and biotechnology industries. Walter has served in a variety of leadership roles, including Member of the Board of Directors, Member of the Board of Managers, and Member of the Board of Directors. In these roles, they have been responsible for providing strategic direction, overseeing operations, and developing business plans.

Ogier has a deep understanding of the drug development process, from early discovery through clinical development and commercialization. Walter has played a key role in the development and commercialization of several drugs, including ricolinostat (a small molecule, oral, selective inhibitor of histone deacetylase 6), which is used to treat peripheral neuropathy and neuropathic pain.

Ogier received their MBA from the University of Chicago Booth School of Business.

Walter Ogier received their MBA from Yale School of Management with an emphasis in marketing and finance. Walter also holds a BA from Williams College in Chemistry. Prior to attending Yale, they attended The Webb Schools and Foothill Country Day School.